These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 377556)

  • 21. [Epidemiology, immunology, and methods for the detection of inhibitors in haemophilia (author's transl)].
    Ortega F; Martin Villar J; Magallon M
    Sangre (Barc); 1978; 23(5B):688-98. PubMed ID: 725713
    [No Abstract]   [Full Text] [Related]  

  • 22. Markers for the factor VIII antibody response in hemophilia A.
    Shapiro SS
    Scand J Haematol Suppl; 1984; 40():181-5. PubMed ID: 6433450
    [No Abstract]   [Full Text] [Related]  

  • 23. [Circulating anticoagulants against coagulation factors with special reference to anti-factor VIII:C].
    Aznar JA
    Sangre (Barc); 1985; 30(4-C):813-8. PubMed ID: 3937252
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of anti-factor VIII antibodies.
    Blatt PM; White GC; McMillan CW; Roberts HR
    Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-DR and Factor VIII antibodies in hemophilia A.
    Mayr WR; Lechner K; Niessner H; Pabinger-Fasching I
    Thromb Haemost; 1984 Apr; 51(2):293. PubMed ID: 6429887
    [No Abstract]   [Full Text] [Related]  

  • 27. [Factor VIII inhibitor in multitransfused hemophiliacs. A finding of varying therapeutic consequences].
    Ly B; Evensen SA; Stavem P
    Tidsskr Nor Laegeforen; 1977 Apr; 97(12):554-6, 8. PubMed ID: 854906
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunosuppressive therapy in hematology (author's transl)].
    Deubelbeiss KA
    Ther Umsch; 1979 May; 36(5):426-31. PubMed ID: 451955
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inhibitor hemophilia in oral surgery].
    Schulz S
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
    [No Abstract]   [Full Text] [Related]  

  • 30. Idiopathic inhibitor of factor VIII and its treatment by immunosuppression.
    Ting HC; Wang F; Por P; Nurulhuda A
    Acta Haematol; 1980; 64(4):236-8. PubMed ID: 6781207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
    Zech R; Strother SV
    J Oral Maxillofac Surg; 1983 Jan; 41(1):53-6. PubMed ID: 6217303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIII inhibitors. Etiology, characterization, natural history, and management.
    Lusher JM
    Ann N Y Acad Sci; 1987; 509():89-102. PubMed ID: 3122623
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-factor-VIII inhibitors in haemophilia.
    Lancet; 1989 Aug; 2(8659):363-4. PubMed ID: 2569554
    [No Abstract]   [Full Text] [Related]  

  • 34. Overcoming factor VIII inhibitors: a possible new approach.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Scand J Haematol Suppl; 1984; 40():207-12. PubMed ID: 6433453
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibitors in the first phase of blood coagulation (author's transl)].
    Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):458-71. PubMed ID: 4799439
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of haemophiliacs who have antibodies to factor VIII.
    Rizza CR
    Scand J Haematol Suppl; 1984; 40():187-93. PubMed ID: 6433451
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 38. Prothrombin complex concentrates and inhibitors. A reappraisal.
    Kasper CK
    JAMA; 1984 Jan; 251(1):68-9. PubMed ID: 6418899
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
    Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
    Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rapid development of an IgM inhibitor of porcine factor VIII in a patient with acquired haemophilia.
    Weston Smith SG; Revell P; Lawrie AS; Holland LJ; Savidge GF
    Br J Haematol; 1990 Jul; 75(3):434-6. PubMed ID: 2117466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.